Cargando…

Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study

BACKGROUND: The burden and duration of persistent symptoms after nonsevere coronavirus disease 2019 (COVID-19) remains uncertain. This study aimed to assess postinfection symptom trajectories in home-isolated COVID-19 cases compared with age- and time- matched seronegative controls, and investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fjelltveit, Elisabeth B, Blomberg, Bjørn, Kuwelker, Kanika, Zhou, Fan, Onyango, Therese B, Brokstad, Karl A, Elyanow, Rebecca, Kaplan, Ian M, Tøndel, Camilla, Mohn, Kristin G I, Özgümüş, Türküler, Cox, Rebecca J, Langeland, Nina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384725/ https://www.ncbi.nlm.nih.gov/pubmed/35959897 http://dx.doi.org/10.1093/cid/ciac655

Ejemplares similares

SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients
por: Onyango, Therese Bredholt, et al.
Publicado: (2023)

Point-of-Care Influenza Testing Impacts Clinical Decision, Patient Flow, and Length of Stay in Hospitalized Adults( )
por: Fjelltveit, Elisabeth B, et al.
Publicado: (2020)

Post COVID-19 condition after delta infection and omicron reinfection in children and adolescents
por: Ertesvåg, Nina Urke, et al.
Publicado: (2023)

Long COVID in a prospective cohort of home-isolated patients
por: Blomberg, Bjørn, et al.
Publicado: (2021)

SARS-CoV-2–Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study
por: Trieu, Mai-Chi, et al.
Publicado: (2020)

Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study
por: Kuwelker, Kanika, et al.
Publicado: (2021)

Durable immune responses after BNT162b2 vaccination in home-dwelling old adults
por: Hansen, Lena, et al.
Publicado: (2023)

Longevity of B-Cell and T-Cell Responses After Live Attenuated Influenza Vaccination in Children
por: Mohn, Kristin G.-I., et al.
Publicado: (2015)

Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients
por: Mohn, Kristin G.-I., et al.
Publicado: (2022)

Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination
por: Mohn, Kristin G. I., et al.
Publicado: (2017)

Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers
por: Bansal, Amit, et al.
Publicado: (2023)

Live Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils
por: Mohn, Kristin Greve-Isdahl, et al.
Publicado: (2016)

Early Induction of Cross-Reactive CD8(+) T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children
por: Mohn, K G-I, et al.
Publicado: (2020)

Live-Attenuated Influenza Vaccine Induces Tonsillar Follicular T Helper Cell Responses That Correlate With Antibody Induction
por: Lartey, Sarah, et al.
Publicado: (2020)

Use of probiotics to reduce infections and death and prevent colonization with extended-spectrum beta-lactamase (ESBL)-producing bacteria among newborn infants in Tanzania (ProRIDE Trial): study protocol for a randomized controlled clinical trial
por: Kuwelker, Kanika, et al.
Publicado: (2021)

SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity
por: Mohn, Kristin G-I, et al.
Publicado: (2023)

Long COVID: A growing problem in need of intervention
por: Blomberg, Bjørn, et al.
Publicado: (2022)

The Performances of Three Commercially Available Assays for the Detection of SARS-CoV-2 Antibodies at Different Time Points Following SARS-CoV-2 Infection
por: Syre, Heidi, et al.
Publicado: (2022)

Delirium screening with 4AT in patients aged 65 years and older admitted to the Emergency Department with suspected sepsis: a prospective cohort study
por: Myrstad, Marius, et al.
Publicado: (2021)

Seroconversion in household members of COVID-19 outpatients
por: Cox, Rebecca J, et al.
Publicado: (2021)

Starvation to Glucose Reprograms Development of Neurovascular Unit in Embryonic Retinal Cells
por: Özgümüs, Türküler, et al.
Publicado: (2021)

Seasonal influenza vaccination expands hemagglutinin-specific antibody breadth to older and future A/H3N2 viruses
por: Ertesvåg, Nina Urke, et al.
Publicado: (2022)

SARS CoV-2 Infection among Health Care Workers from Different Health Care Facilities in Western Norway: A Prospective, Cross-Sectional Study
por: Kittang, Bård Reiakvam, et al.
Publicado: (2022)

The expression of B & T cell activation markers in children's tonsils following live attenuated influenza vaccine
por: Panapasa, Jack A, et al.
Publicado: (2015)

Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Exhaled Aerosols and Efficacy of Masks During Early Mild Infection
por: Adenaiye, Oluwasanmi O, et al.
Publicado: (2021)

A novel, single-amplification PCR targeting mitochondrial genome highly sensitive and specific in diagnosing malaria among returned travellers in Bergen, Norway
por: Haanshuus, Christel G, et al.
Publicado: (2013)

Single amplification PCR targeting mitochondrial genome more sensitive in diagnosing malaria than nested 18S PCR among returned travelers in Bergen, Norway
por: Haanshuus, Christel Gill, et al.
Publicado: (2012)

A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern
por: Ertesvåg, Nina Urke, et al.
Publicado: (2022)

Are low SARS-CoV-2 viral loads in infected children missed by RT-PCR testing?
por: Langeland, Nina, et al.
Publicado: (2021)

Prevalence and predictors of post-COVID-19 symptoms in general practice - a registry-based nationwide study
por: Hetlevik, Øystein, et al.
Publicado: (2023)

Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study
por: Mukae, Hiroshi, et al.
Publicado: (2022)

Etiology of Cellulitis and Clinical Prediction of Streptococcal Disease: A Prospective Study
por: Bruun, Trond, et al.
Publicado: (2015)

Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children
por: Aamodt, Håvard, et al.
Publicado: (2015)

Assessment of malaria real-time PCR methods and application with focus on low-level parasitaemia
por: Haanshuus, Christel Gill, et al.
Publicado: (2019)

Predictors of SARS-CoV-2 RNA From Nasopharyngeal Swabs and Concordance With Other Compartments in Nonhospitalized Adults With Mild to Moderate COVID-19
por: Moser, Carlee, et al.
Publicado: (2022)

High Prevalence of Humoral and Cellular Immunity to Influenza Viruses in Preschool Children Living in Addis Ababa, Ethiopia
por: Dembinski, Jennifer L., et al.
Publicado: (2017)

Influence of Mild White Matter Lesions on Voxel-based Morphometry
por: Goto, Masami, et al.
Publicado: (2020)

Efficacy and Safety of Adintrevimab (ADG20) for the Treatment of High-Risk Ambulatory Patients With Mild or Moderate Coronavirus Disease 2019: Results From a Phase 2/3, Randomized, Placebo-Controlled Trial (STAMP) Conducted During Delta Predominance and Early Emergence of Omicron
por: Ison, Michael G, et al.
Publicado: (2023)

Not just antibodies: B cells and T cells mediate immunity to COVID-19
por: Cox, Rebecca J., et al.
Publicado: (2020)

Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019
por: Streinu-Cercel, Anca, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_53mhsulv8hm4kbteg3sjapf5fs